Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy

Lancet

Volumn 352, Issue 9144, 1998, Pages 1904-

  Thomson, Andrew J ^b   Walker, Isobel D ^b   Greer, Ian A ^a  

^a Glasgow Roy Matern Hosp/Glasgow ^*  (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBOPLASTIN;

ANTICOAGULATION; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; DELIVERY; FEMALE; HUMAN; LUNG EMBOLISM; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

EID: 0032512299     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60394-7     Document Type: Article

References (5)

1. 1 Department of Health, Welsh Office, Scottish Home, and Health Department and Department of Health and Social Services Northern Ireland. Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-96. London: Stationery Office, 1998.
2. 2 Simmoneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-69.
3. 3 Nelson-Piercy C. Hazards of heparin. In: Greer IA, ed. Thromboembolic disease in obstetrics and gynaecology. Balliéte's Clin Obstet Gynaecol 1997; 11: 489-509.
4. 4 Greer IA. Special case of venous thromboembolism in pregnancy. In Tooke JE, Lowe GDO, eds. A textbook of vascular medicine. London: Arnold, 1996.
5. 5 Hyers TM, Hull RD, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 1995; 108 (suppl): 335S-51.